fda banning semaglutide Ban on Compounded GLP-1 Drugs: What to Know U.S. FDA finds no evidence

Build sustainable habits for nutrition, mindset, and long-term success beyond medication.

Find in-network dietitians and nutritionists with minimal out-of-pocket costs

Design emails and forms that look great on any device

For patients experiencing more significant skin changes following weight loss, topical skincare may be complemented with personalised in-clinic treatments

The Indian Medical Association is seeking government intervention to regulate GLP-1 weight-loss drugs

Although glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have been used as anti-obesity agents, there are individual differences between these agents, thus making it difficult to achieve optimal treatment efficacy